References
- TargumSDAbbottJLPsychosis in the elderly: a spectrum of disordersJ Clin Psychiatry199960Suppl 841010335666
- HarrisMJJesteDVLate-onset schizophrenia: an overviewSchizophr Bull198814139553291094
- Trans-JohnsonTKKrullAJJesteDVLate-life schizophrenia and its treatment: pharmacologic issues in older schizophrenia patientsClin Geriatr Med199284014101350940
- JesteDVFinkelSIPsychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndromeAm J Geriatr Psychiatry20008293410648292
- McKeithIGFairburnABothwellRAAn evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body typeNeurology1994448728778190290
- KuzuharaSDrug-induced psychotic symptoms in Parkinson’s disease. Problems, management and dilemmaJ Neurol2001248Suppl 3III283111697685
- KarimSByrneEJTreatment of psychosis in elderly peopleAdv Psychiatr Treat200511286296
- RitchieCWChiuEHallidaySA comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months durationInt J Geriatr Psychiatry20062117117916416458
- MalhotraSKaranRSPandhiPDrug related medical emergencies in the elderly: role of adverse drug reactions and non-compliancePostgrad Med J20017770370711677279
- LeibermanJAStroupTSMcEvoyJPEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med20053531209122316172203
- PerkinsDOPredictors of non-compliance in patients with schizophreniaJ Clin Psychiatry2002631121112812523871
- MasandPSGuptaSLong-acting injectable antipsychotics in the elderlyDrugs Aging2003201099111014651433
- StahlSMAntipsychotic agentsStahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Applications3rd edNew York, NYCambridge University Press2008327453
- MIMS AustraliaRisperdal ConstaMIMS online2009Accessed May 21, 2009 Available from: http://www.mims.com.au/
- VolkowNDWangGJFowlerJSParallel loss of presynaptic and post synaptic dopamine markers in normal ageingAnn Neurol1998441431479667606
- KaneJMEerdekensMLindenmayerJPLong-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychoticAm J Psychiatry20031601125113212777271
- MöllerHJLiorcaPMSacchettiEEfficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapiesInt Clin Psychopharmacol20052012113015812261
- NiazOSHaddardPMThirty five months experience of risperidone long-acting injection in a UK psychiatric service including mirror image analysis of in-patient careActa Psychiatr Scand2007116364617559599
- LasserRABossieCAZhuYEfficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorderInt J Geriatr Psychiatry20041989890515352149
- KisslingWGluePMedoriRSimpsonSLong term safety and efficacy of long-acting risperidone in elderly psychotic patientsHum Psychopharmacol Clin Exp200722505513
- Hudson-JessopPHughesBBrinkleyNNew for old? Risperidone long-acting injection in older patientsAustralas Psychiatry20071546146417999255
- SinghDO’ConnorDWDepot risperidone: the experience of an Australian aged psychiatry serviceInt Psychogeriatr20071978979217726767
- TadgerSBaruchYBarakYSymptomatic remission in elderly schizophrenia patients treated with long-acting risperidoneInt Psychogeriatr2008201245125018620626
- Committee on Safety of MedicinesAtypical anti-psychotic drugs and stroke2004Accessed May 21, 2009 Available from: http://www.mca.gov.uk/auwork/monitorsafequalmed/safetymessages/antipsychotic_qa.htm
- SchneiderLSDagermanKSInselPRisk of death with atypical anti-psychotic drug treatment for dementia. Meta-analysis of randomized placebo- controlled trialsJAMA20052941934194316234500
- HerrmannNMamdaniMLanctotKLAtypical antipsychotics and the risk of cerebrovascular accidentsAm J Psychiatry20041611113111515169702
- PettyRGProlactin and antipsychotic medication: mechanism of actionSchizophr Res199935SupplS677310190227
- MaguireGAProlactin elevation with antipsychotic medication: mechanism of action and clinical consequencesJ Clin Psychiatry200263Suppl 4S5662